FZD1 and central nervous system cancer: To determine whether Fz1 is signaling in gliomas as a consequence of Wg-Fz1 interaction, we used an anti-Armadillo (Arm) antibody, which identifies its cytoplasmic inactive form (Cyt-Arm) [63].